41 results
8-K
EX-99.1
BPMC
Blueprint Medicines Corp
2 May 24
Blueprint Medicines Reports Strong First Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
7:09am
the company to maintain a durable capital position to achieve a self-sustainable financial profile.
Key Upcoming Milestones
The company plans … cash and investments provide a durable capital position which enables the company to reach a self-sustainable profile.
Conference Call Information
8-K
EX-99.1
BPMC
Blueprint Medicines Corp
15 Feb 24
Blueprint Medicines Reports Fourth Quarter and Full Year 2023 Results
7:05am
a self-sustainable financial profile.
Key Upcoming Milestones
The company plans to achieve the following milestones in the first half of 2024:
Mast cell … the company to reach a self-sustainable profile.
Conference Call Information
Blueprint Medicines will host a live conference call and webcast at 8:00
8-K
EX-99.1
0em1v6
8 Jan 24
Blueprint Medicines Highlights 2024 Corporate Strategy and Business Priorities at 42nd Annual J.P. Morgan Healthcare Conference
8:03am
8-K
EX-99.2
zg2e6 rkswk3pa
8 Jan 24
Blueprint Medicines Highlights 2024 Corporate Strategy and Business Priorities at 42nd Annual J.P. Morgan Healthcare Conference
8:03am
8-K
EX-99.1
7te04m3kaxpw99b
26 Oct 23
Blueprint Medicines Reports Third Quarter 2023 Results
7:00am
8-K
EX-99.1
81qudbf nzoke2ko
4 May 23
Blueprint Medicines Reports First Quarter 2023 Results
7:18am
8-K
EX-99.1
bn3e nbtbi
1 Nov 22
Blueprint Medicines Outlines 2027 Blueprint to Achieve Precision Medicine at Scale
8:08am
8-K
EX-99.2
og4pdgtq90lavbigohlr
1 Nov 22
Blueprint Medicines Outlines 2027 Blueprint to Achieve Precision Medicine at Scale
8:08am
8-K
EX-99.1
6ds9 raj8
2 Aug 22
Blueprint Medicines Reports Second Quarter 2022 Results
7:47am
8-K
EX-99.1
pxi8fis
3 May 22
Blueprint Medicines Reports First Quarter 2022 Results
7:45am